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Elevated Lyme Disease Seroprevalence Among Dogs in a 
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Abstract
Lyme disease, a tick-borne illness caused by Borrelia burgdorferi, infects humans and other 
species, including dogs. Canine seroprevalence has been suggested as a sentinel marker of human 
disease risk. A recent publication reported high canine seroprevalence (> 5%) in Routt County, 
Colorado, an area where Lyme disease is generally considered nonendemic. We surveyed 
veterinarians in Routt County and discovered that 11 of 12 seropositive dogs (> 90%) had a 
documented history of travel to or residence in a Lyme disease endemic area. These findings do 
not support the presence of an undocumented disease focus and reveal that despite its high 
sensitivity, there are limitations in the specificity and positive predictive value of elevated canine 
seroprevalence as a marker of human risk.
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Introduction
Lyme disease is a tick-borne illness caused by certain genospecies of Borrelia burgdorferi. 
Areas of known transmission include the northeastern, mid-Atlantic, and north-central 
United States where the vector is Ixodes scapularis, and California, Oregon, and 
Washington where the vector is I. pacificus. Disease manifestations in humans include 
erythema migrans, carditis, arthritis, and neurologic abnormalities. Domestic dogs are also 
highly susceptible to infection, although clinical illness is less common (Little et al. 2010).
Routt County is a small rural county in northwestern Colorado where transmission of B. 
burgdorferi to humans has never been documented, and known tick vector species have not 
been identified (Dennis et al. 1998). In 2009, Bowman and colleagues reported that over 5% 
of Routt County dogs tested had detectable antibodies to B. burgdorferi (Bowman et al. 
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2009). These results were based on a nationwide convenience sample of dogs tested using 
IDEXX SNAP® tests, which simultaneously detect infection with Dirofilaria immitis, 
Ehrlichia canis, and B. burgdorferi. This publication, in conjunction with a map on an 
IDEXX website showing 17 seropositive dogs in Routt County (IDEXX 2010), generated 
concern that a previously unrecognized enzootic cycle of B. burgdorferi with consequent 
risk of human infection was present in Colorado. To assess this possibility, we conducted a 
survey of Routt County veterinarians.
Materials and Methods
In collaboration with the Colorado Veterinary Medical Association, we obtained contact 
information for all known licensed veterinary practitioners in Routt County. In June, 2010, 
each practice was contacted by telephone to determine if they provided service for canines, 
and, if so, whether they ever had a patient that tested positive for Lyme disease. 
Veterinarians that met these criteria were asked to complete a brief written survey, referring 
as needed to medical charts or electronic clinic records. Questions concerned practice 
characteristics, the number of dogs testing positively for Lyme disease during the preceding 
decade (2001–2010), and the clinical features, tests used, and travel history of any sero-
positive dogs. Surveys were administered using a combination of telephone, e-mail, and fax.
Results
Sixteen of 20 veterinary practitioners licensed in Routt County were contacted successfully; 
the remaining 4 could not be located. Ten practitioners reported treating canines. Two did 
not report ever having a seropositive dog in their practice and were not queried further. All 
of the remaining 8 practitioners agreed to participate in the survey.
Participating practitioners were associated with 3 clinics, each treating ≥500 dogs annually. 
Participants identified a total of 12 dogs that tested positively for antibodies to B. 
burgdorferi during the 10-year period. Positive results were obtained with IDEXX SNAP® 
3Dx®, 4Dx®, and IDEXX Lyme Quant C6® tests, as well as 1 unspecified off-site 
diagnostic test. Eleven (92%) of the dogs had a history of residence in a state where Lyme 
disease is known to be highly endemic (Maine, New Jersey, Connecticut, Maryland, or 
Minnesota). The remaining seropositive dog had a “low titer” when tested with the IDEXX 
Lyme Quant C6® test, despite having no documented history of travel outside of Colorado 
and no clinical signs. Additionally, this dog reportedly tested positively for Rickettsia 
rickettsii and an Ehrlichia species using an unspecified IDEXX tick panel.
Discussion
Dogs have been proposed as sentinels for Lyme disease risk based on their proclivity for tick 
bites and a robust antibody response following infection (Rand et al. 1991, Duncan et al. 
2005, Little et al. 2010). High seroprevalence rates of 7–18% among dogs in endemic states 
support the view of canine serology as a sensitive tool for identifying areas with infected 
ticks (Bowman et al. 2009; Mead et al. 2011). Our investigation concerns an alternate 
characteristic, the specificity of high canine seroprevalence as a marker of risk. We surveyed 
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veterinarians in a county with no prior recognized Lyme disease risk and found that all but 1 
of 12 seropositive dogs had a documented history of prior travel to or residence in a highly 
endemic area. The 12th dog was seroreactive to B. burgdorferi and 2 other diseases rarely 
seen in Colorado, suggesting either a highly unusual exposure history, or perhaps some 
immunological characteristic leading to nonspecific reactivity. Regardless, our findings do 
not support the existence of an undocumented enzootic cycle of Lyme disease in Routt 
County.
Our investigation is subject to several limitations. We did not determine the total number of 
Lyme disease tests performed in the county and cannot validate the >5% seroprevalence 
previously reported (Bowman et al. 2009). Whereas the IDEXX website listed a total of 17 
positive results from Routt County between 2001 and 2009 (IDEXX 2010), we were only 
able to identify 12 seropositive dogs. Nevertheless, we have no reason to suspect differential 
ascertainment of dogs with a history of travel, and the overall conclusion is likely 
unaffected.
Canine seroprevalence data are sometimes touted as less subject to misrepresentation as 
compared to human disease surveillance data, due to presumption of more limited animal 
movement (Duncan et al. 2005). Travel-related exposures, small sample sizes, and selective 
testing of dogs with the potential for previous exposure, however, can generate high rates of 
seropositivity that do not accurately reflect local risk. In this regard, maps of canine 
seroprevalence are subject to some of the same limitations as those of human surveillance 
data. Proper interpretation of elevated canine seroprevalence requires an appreciation of 
both its sensitivity and potential specificity. As a sensitive but potentially nonspecific 
marker of risk, the greatest utility of canine seroprevalance information lies in validation of 
low risk in areas where the disease does not occur.
Acknowledgments
This work was supported by the Centers for Disease Control and Prevention. We would like to thank the Colorado 
Veterinary Medical Association for their assistance in carrying out this survey. We are grateful to the veterinarians 
that took the time to participate.
References
Bowman D, Little SE, Lorentzen L, Shields J, et al. Prevalence and geographic distribution of 
Dirofilaria immitis, Borrelia burgdorferi, Ehrlichia canis, and Anaplasma phagocytophilum in dogs 
in the United States: Results of a national clinic-based serologic survey. Vet Parasitol. 2009; 
160:138–148. [PubMed: 19150176] 
Dennis DT, Nekomoto TS, Victor JC, Paul WS, et al. Reported distribution of Ixodes scapularis and 
Ixodes pacificus (Acari: Ixodidae) in the United States. J Med Entomol. 1998; 35:629–638. 
[PubMed: 9775584] 
Duncan AW, Correa MT, Levine JF, Breitschwerdt EB. The dog as a sentinel for human infection: 
Prevalence of Borrelia burgdorferi C6 antibodies in dogs from southeastern and mid-Atlantic states. 
Vector Borne Zoonotic Dis. 2005; 5:101–109. [PubMed: 16011425] 
IDEXX. [Accessed January 2013] Available at www.dogsandticks.com/diseases_in_your_area.php
Little SE, Heise SR, Blagburn BL, Callister SM, et al. Lyme borreliosis in dogs and humans in the 
USA. Trends Parasitol. 2010; 26:213–218. [PubMed: 20207198] 
Mead PS, Goel R, Kugeler KJ. Canine serology as adjunct to human Lyme disease surveillance. 
Emerg Infect Dis. 2011; 17:1710–1712. [PubMed: 21888800] 
Millen et al. Page 3













Rand PW, Smith RP Jr, Lacombe EH. Canine seroprevalence and the distribution of Ixodes daminini 
in an area of emerging Lyme disease. Am J Public Health. 1991; 81:1331–1334. [PubMed: 
1928538] 
Millen et al. Page 4
Vector Borne Zoonotic Dis. Author manuscript; available in PMC 2016 January 06.
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
